Absorbable Hemostatic Fluid Gelatin Trial
NCT: NCT07830797 · NOT_YET_RECRUITING
Brief Summary
This is a multicenter, single-blind, randomized controlled, non-inferiority trial evaluating the safety and efficacy of an absorbable hemostatic fluid gelatin for surgical hemostasis. Subjects are patients undergoing elective/semi-elective surgeries in General Surgery, Orthopedics, and Gynecology. The test group receives the investigational device, while the control group receives a marketed predicate device (SURGIFLO). The primary outcome is the 5-minute hemostasis success rate at the Target Bleeding Site (TBS).
Frequently Asked Questions
What is Absorbable Hemostatic Fluid Gelatin Trial?
Absorbable Hemostatic Fluid Gelatin Trial is a clinical trial registered under NCT07830797. Current status: NOT_YET_RECRUITING.
What is the status of NCT07830797?
The current status of NCT07830797 (Absorbable Hemostatic Fluid Gelatin Trial) is: NOT_YET_RECRUITING.
When did Absorbable Hemostatic Fluid Gelatin Trial start?
Absorbable Hemostatic Fluid Gelatin Trial started on 2026-09-08.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.